Yanshan Technology has set up a new subsidiary in Shanghai. According to the enterprise search APP, Shanghai Yunsong Technology Co., Ltd. was recently established with Zhang Weiming as the legal representative and a registered capital of 10 million yuan. Its business scope includes technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion. Enterprise equity penetration shows that the company is wholly owned by Yanshan Technology.Yonhap News Agency: South Korean Prime Minister Han Dezhu blamed himself for failing to stop martial law.The three departments issued the tax policy on the transformation of operating cultural institutions into enterprises in the cultural system reform, and the Ministry of Finance, the State Administration of Taxation and the Central Propaganda Department issued the Announcement on the Tax Policy on the Transformation of Operating Cultural Institutions into Enterprises in the Cultural System Reform, which mentioned that operating cultural institutions can enjoy the following transitional tax preferential policies: if operating cultural institutions are transformed into enterprises before December 31, 2022, they will be exempted from enterprise income tax from the date of registration of transformation to December 31, 2027. If a cultural unit funded by the financial department is transformed into an enterprise before December 31, 2022, its self-use property will be exempted from property tax from the date of registration of transformation to December 31, 2027.
India's SENSEX30 index opened 0.07% higher at 81,568.39 points. Among the constituent stocks, ULTRATECH CEMENT opened 1% higher, Asian Coatings rose 0.74% and BAJAJ FINANCE rose 0.62%. In terms of decline, Mahengda Information Technology opened 0.44% lower, India Industrial Credit Investment Bank fell 0.33%, and HCL TECHNOLOGIES fell 0.26%.Market news: Japan is considering levying a 4% corporate tax surcharge for national defense expenditure.
The kitchen & bathroom appliances sector rose to 3 boards of Shuaifeng in the short term, and the kitchen & bathroom appliances sector rose to 3 boards of Shuaifeng, followed by Martians, Yitian Intelligent, Op Technology, Vantage and Wanhe Electric.Celeste's new patent can be used for early warning of safe driving according to sitting posture. Tianyuecha's intellectual property information shows that recently, the patent of "vehicle driving early warning method, device, electronic equipment and storage medium" applied by Celeste Automobile Co., Ltd. was announced. The method includes: collecting the sitting image of the vehicle driver, identifying the key points in the sitting image, using waist key points and shoulder key points to determine the current sitting centroid, comparing the current sitting centroid with the initial sitting centroid, generating a centroid deviation result, detecting whether the vehicle driver's sitting posture is abnormal according to the centroid deviation result, and giving an early warning prompt to the vehicle driver in response to determining that the vehicle driver's sitting posture is abnormal. According to the invention, the key points of the driver's waist and shoulders are intelligently detected through the sitting posture image to obtain the position of the triangle centroid of the driver's shoulder and waist, and the sitting posture is judged by adopting the sitting posture centroid, so that whether the driver's sitting posture is abnormal can be quickly and accurately recognized, the accuracy of judging the driving sitting posture is improved, the driving warning is automatically performed, and the effectiveness of safe driving of vehicles is ensured.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14